GB9516760D0 - Organic compounds - Google Patents

Organic compounds

Info

Publication number
GB9516760D0
GB9516760D0 GBGB9516760.7A GB9516760A GB9516760D0 GB 9516760 D0 GB9516760 D0 GB 9516760D0 GB 9516760 A GB9516760 A GB 9516760A GB 9516760 D0 GB9516760 D0 GB 9516760D0
Authority
GB
United Kingdom
Prior art keywords
organic compounds
compounds
organic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9516760.7A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Priority to GBGB9516760.7A priority Critical patent/GB9516760D0/en
Publication of GB9516760D0 publication Critical patent/GB9516760D0/en
Priority to KR1019980701110A priority patent/KR19990036440A/ko
Priority to SK193-98A priority patent/SK19398A3/sk
Priority to JP9508953A priority patent/JPH11513025A/ja
Priority to CN96196311A priority patent/CN1193353A/zh
Priority to EP96929263A priority patent/EP0846178A1/en
Priority to IL12289896A priority patent/IL122898A0/xx
Priority to HU9802349A priority patent/HUP9802349A3/hu
Priority to CZ98437A priority patent/CZ43798A3/cs
Priority to TR1998/00214T priority patent/TR199800214T1/xx
Priority to BR9610239A priority patent/BR9610239A/pt
Priority to PCT/EP1996/003616 priority patent/WO1997007218A1/en
Priority to PL96324897A priority patent/PL324897A1/xx
Priority to AU68735/96A priority patent/AU6873596A/en
Priority to CA002227795A priority patent/CA2227795A1/en
Priority to NO980566A priority patent/NO980566L/no
Priority to MXPA/A/1998/001253A priority patent/MXPA98001253A/xx
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43531—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from mites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against Fc-receptors, e.g. CD16, CD32, CD64
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Insects & Arthropods (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GBGB9516760.7A 1995-08-16 1995-08-16 Organic compounds Pending GB9516760D0 (en)

Priority Applications (17)

Application Number Priority Date Filing Date Title
GBGB9516760.7A GB9516760D0 (en) 1995-08-16 1995-08-16 Organic compounds
CA002227795A CA2227795A1 (en) 1995-08-16 1996-08-16 Allergen-xcd32 fusion proteins
CZ98437A CZ43798A3 (cs) 1995-08-16 1996-08-16 Fúzní proteiny, způsob jejich přípravy a farmaceutický přípravek, který je obsahuje
BR9610239A BR9610239A (pt) 1995-08-16 1996-08-16 Proteínas de fusão-alérgeno-xcd32
JP9508953A JPH11513025A (ja) 1995-08-16 1996-08-16 アレルゲン−ｘｃｄ３２融合タンパク質
CN96196311A CN1193353A (zh) 1995-08-16 1996-08-16 变应原－xcd32融合蛋白
EP96929263A EP0846178A1 (en) 1995-08-16 1996-08-16 Allergen-xcd32 fusion proteins
IL12289896A IL122898A0 (en) 1995-08-16 1996-08-16 Allergan -XCD32 fusion proteins
HU9802349A HUP9802349A3 (en) 1995-08-16 1996-08-16 Allergen-xcd32 fusion proteins and process of making anti-allergenic pharmaceutical product
KR1019980701110A KR19990036440A (ko) 1995-08-16 1996-08-16 알러젠-ｘｃｄ３２융합 단백질
TR1998/00214T TR199800214T1 (xx) 1995-08-16 1996-08-16 Allerjen-XCD32 f�zyon proteinler.
SK193-98A SK19398A3 (en) 1995-08-16 1996-08-16 Allergen-xcd32 fusion proteins
PCT/EP1996/003616 WO1997007218A1 (en) 1995-08-16 1996-08-16 Allergen-xcd32 fusion proteins
PL96324897A PL324897A1 (en) 1995-08-16 1996-08-16 Proteinous allergen-xcd32 fusions
AU68735/96A AU6873596A (en) 1995-08-16 1996-08-16 Allergen-xcd32 fusion proteins
NO980566A NO980566L (no) 1995-08-16 1998-02-10 Allergen-XCD32 fusjonsproteiner
MXPA/A/1998/001253A MXPA98001253A (en) 1995-08-16 1998-02-13 Allergen fusion proteins -xc

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9516760.7A GB9516760D0 (en) 1995-08-16 1995-08-16 Organic compounds

Publications (1)

Publication Number Publication Date
GB9516760D0 true GB9516760D0 (en) 1995-10-18

Family

ID=10779307

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9516760.7A Pending GB9516760D0 (en) 1995-08-16 1995-08-16 Organic compounds

Country Status (16)

Country Link
EP (1) EP0846178A1 (zh)
JP (1) JPH11513025A (zh)
KR (1) KR19990036440A (zh)
CN (1) CN1193353A (zh)
AU (1) AU6873596A (zh)
BR (1) BR9610239A (zh)
CA (1) CA2227795A1 (zh)
CZ (1) CZ43798A3 (zh)
GB (1) GB9516760D0 (zh)
HU (1) HUP9802349A3 (zh)
IL (1) IL122898A0 (zh)
NO (1) NO980566L (zh)
PL (1) PL324897A1 (zh)
SK (1) SK19398A3 (zh)
TR (1) TR199800214T1 (zh)
WO (1) WO1997007218A1 (zh)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9724531D0 (en) 1997-11-19 1998-01-21 Smithkline Biolog Novel compounds
JP2002529048A (ja) 1997-12-02 2002-09-10 メダレツクス・インコーポレーテツド 抗−Ｆｃ受容体結合成分を発現する細胞
EP1221317A1 (en) * 2000-12-28 2002-07-10 SHAN-Beteiligungsgesellschaft m.b.H. Vaccines containing hybrid polypeptides consisting of at least two different allergenic proteins
US8025873B2 (en) 2002-06-20 2011-09-27 Paladin Labs, Inc. Chimeric antigens for eliciting an immune response
US8029803B2 (en) 2002-06-20 2011-10-04 Paladin Labs, Inc. Chimeric antigens for eliciting an immune response
US8007805B2 (en) 2003-08-08 2011-08-30 Paladin Labs, Inc. Chimeric antigens for breaking host tolerance to foreign antigens
BG65715B1 (bg) * 2003-09-04 2009-08-31 Чавдар ВАСИЛЕВ Средство за селективно подтискане на патологични днк - специфични в клетки
BG65954B1 (bg) * 2005-01-05 2010-07-30 Чавдар ВАСИЛЕВ Средство за селективно подтискане активността на патологични автореактивни в-клетки
EP1829895A1 (en) * 2006-03-03 2007-09-05 f-star Biotechnologische Forschungs- und Entwicklungsges.m.b.H. Bispecific molecule binding TLR9 and CD32 and comprising a T cell epitope for treatment of allergies
US9636415B2 (en) 2006-03-03 2017-05-02 S-Target Therapeutics Gmbh Bispecific molecule binding TLR9 and CD32 and comprising a T cell epitope for treatment of allergies
KR102107646B1 (ko) 2012-06-15 2020-05-08 이뮤노믹 쎄라퓨틱스, 인크. 알레르기 치료용 핵산
US10434170B2 (en) 2012-07-13 2019-10-08 S-Target Therapeutics Gmbh Immunoregulatory vaccine
AU2013340899B2 (en) * 2012-11-01 2017-10-05 Veterinaerinstituttet New fusion proteins for the treatment of allergic diseases
US9005630B2 (en) 2012-11-01 2015-04-14 Veterinaerinstituttet Fusion proteins for the treatment of allergic diseases
EP2999485B1 (en) 2013-05-21 2018-01-31 Tyg Oncology Ltd. Gastrin peptide immunogenic composition
CN113186167B (zh) * 2021-04-28 2021-11-30 中国食品药品检定研究院 用于测定抗cd20单克隆抗体药物adcp生物学活性的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994024281A1 (en) * 1993-04-14 1994-10-27 Immulogic Pharmaceutical Corporation T cell epitopes of the major allergens from dermatophagoides (house dust mite)
CA2188812A1 (en) * 1994-05-26 1995-12-07 Mark De Boer New methods and compounds for the selective modulation of antigen-specific t-cell responsiveness

Also Published As

Publication number Publication date
CN1193353A (zh) 1998-09-16
MX9801253A (es) 1998-05-31
PL324897A1 (en) 1998-06-22
IL122898A0 (en) 1998-08-16
CZ43798A3 (cs) 1998-06-17
JPH11513025A (ja) 1999-11-09
SK19398A3 (en) 1998-09-09
AU6873596A (en) 1997-03-12
NO980566D0 (no) 1998-02-10
HUP9802349A2 (hu) 1999-01-28
NO980566L (no) 1998-02-10
BR9610239A (pt) 1999-06-15
HUP9802349A3 (en) 1999-04-28
KR19990036440A (ko) 1999-05-25
WO1997007218A1 (en) 1997-02-27
CA2227795A1 (en) 1997-02-27
EP0846178A1 (en) 1998-06-10
TR199800214T1 (xx) 1998-06-22

Similar Documents

Publication Publication Date Title
GB9516760D0 (en) Organic compounds
GB9509156D0 (en) Organic compounds
GB9510477D0 (en) Organic compounds
GB9511486D0 (en) Organic compounds
GB9509159D0 (en) Organic compounds
GB9508365D0 (en) Organic compounds
GB9513013D0 (en) Organic compounds
GB9503092D0 (en) Organic compounds
GB9509157D0 (en) Organic compounds
GB9503950D0 (en) Organic compounds
GB9504073D0 (en) Organic compounds
GB9504074D0 (en) Organic compounds
GB9504287D0 (en) Organic compounds
GB9504332D0 (en) Organic compounds
GB9505080D0 (en) Organic compounds
GB9511046D0 (en) Organic compounds
GB9505860D0 (en) Organic Compounds
GB9506176D0 (en) Organic compounds
GB9506379D0 (en) Organic compounds
GB9506486D0 (en) Organic compounds
GB9507128D0 (en) Organic compounds
GB9507134D0 (en) Organic compounds
GB9501155D0 (en) Organic compounds
GB9507674D0 (en) Organic compounds
GB9510674D0 (en) Organic compounds